This website is intended for healthcare professionals

02 November 2022

Volume 4 | Issue 11

ISSN (Print): 2631-8385

ISSN (Online): 2631-8393


The batches shown in Table 1 of Targocid 200 mg powder for injection/infusion or oral solution are being recalled immediately by Sanofi UK. This is due to out of specification results for bacterial endotoxins, as confirmed by testing of retain samples. This problem was discovered after a medical adverse event in which four patients developed a high grade of fever within three hours of receiving vials from the impacted batches..

More from this issue